|
US4603203A
(en)
|
1983-12-14 |
1986-07-29 |
Takeda Chemical Industries, Ltd. |
3-aminopyrazolo[3,4-d]pyrimidine derivatives and production thereof
|
|
CA1251448A
(en)
|
1985-03-27 |
1989-03-21 |
William J. Coates |
Pyridazinone derivatives
|
|
US4666908A
(en)
|
1985-04-05 |
1987-05-19 |
Warner-Lambert Company |
5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use
|
|
DK0379917T3
(da)
|
1989-01-26 |
1995-12-11 |
Bayer Ag |
Optisk aktive (meth)acrylsyre-drivater, deres fremstilling, deres polymerisation til optisk aktive polymere og disses anvendelse
|
|
NZ238609A
(en)
|
1990-06-21 |
1993-12-23 |
Schering Corp |
Polycyclic guanine derivatives; preparation, pharmaceutical compositions,
|
|
US5294612A
(en)
|
1992-03-30 |
1994-03-15 |
Sterling Winthrop Inc. |
6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
|
|
EP0686157A1
(en)
|
1993-02-26 |
1995-12-13 |
Schering Corporation |
2-benzyl-polycyclic guanine derivatives and process for preparing them
|
|
DE19541264A1
(de)
|
1995-11-06 |
1997-05-07 |
Bayer Ag |
Purin-6-on-derivate
|
|
US5824683A
(en)
|
1995-11-28 |
1998-10-20 |
Schering Corporation |
2'- 4'-halo- 1,1'-biphenyl!-4-yl!methyl!-5'-methyl-spiro cyclopentane-1,7' (8'H)- 3H! imidazo 2,1-b!purin!-4' (5'H)-ones
|
|
DE19702785A1
(de)
|
1997-01-27 |
1998-07-30 |
Bayer Ag |
Neue cyclische Harnstoffderivate
|
|
SE9701398D0
(sv)
|
1997-04-15 |
1997-04-15 |
Astra Pharma Prod |
Novel compounds
|
|
IT1291372B1
(it)
|
1997-05-21 |
1999-01-07 |
Schering Plough S P A |
Uso di analoghi eterociclici di 1,2,4-triazolo (1,5-c) pirimidine per la preparazione di medicamenti utili per il trattamento delle malattie
|
|
US6013621A
(en)
|
1997-10-17 |
2000-01-11 |
The Rockfeller University |
Method of treating psychosis and/or hyperactivity
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
DE19931206A1
(de)
|
1999-07-07 |
2001-01-11 |
Stief Christian |
Arzneimittel zur Erhöhung des cAMP-Spiegels und deren Verwendung
|
|
HK1049834A1
(zh)
|
1999-10-11 |
2003-05-30 |
辉瑞大药厂 |
用作磷酸二酯酶抑制剂的5-(2-取代的-5-杂环基磺酰基吡啶-3-基)-二氢吡唑并[4，3-d]嘧啶-7-酮类化合物
|
|
IL152925A
(en)
|
1999-10-21 |
2010-04-15 |
Pfizer |
Pharmaceutical preparations for the treatment of neurological disease containing an inhibitor of ring guanizine '3', 5 '- monophosphate phosphodiesterase 5 and one of gabapentin or pregabalin
|
|
CN1436080A
(zh)
|
2000-04-19 |
2003-08-13 |
利利艾科斯有限公司 |
环gmp－特异性磷酸二酯酶抑制剂治疗帕金森氏病的用途
|
|
EP1307201B1
(de)
|
2000-08-01 |
2004-11-24 |
Bayer HealthCare AG |
Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung
|
|
DE10064105A1
(de)
|
2000-12-21 |
2002-06-27 |
Bayer Ag |
Neue Substituierte Imidazotriazinone
|
|
DE10108752A1
(de)
|
2001-02-23 |
2002-09-05 |
Bayer Ag |
Neue Substituierte Imidazotriazinone
|
|
SE0102315D0
(sv)
|
2001-06-28 |
2001-06-28 |
Astrazeneca Ab |
Compounds
|
|
JP4450365B2
(ja)
|
2001-08-28 |
2010-04-14 |
シェーリング コーポレイション |
多環式グアニンホスホジエステラーゼｖ阻害剤
|
|
EP1575916B1
(en)
|
2001-08-31 |
2013-05-22 |
The Rockefeller University |
Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
|
|
CN1585771A
(zh)
|
2001-11-09 |
2005-02-23 |
先灵公司 |
多环鸟嘌呤衍生物磷酸二酯酶v抑制剂
|
|
IL163575A0
(en)
|
2002-02-21 |
2005-12-18 |
Univ Rockefeller |
Compositions and method for regulation of calcium-dependent signalling in brain
|
|
AU2003288352A1
(en)
|
2002-10-30 |
2004-06-07 |
Centre National De La Recherche Scientifique (Cnrs) |
Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
|
|
AU2003277562B2
(en)
|
2002-11-06 |
2009-03-26 |
Aska Pharmaceutical Co., Ltd. |
Pyrazolonaphthyridine derivative
|
|
HRP20050848A2
(en)
|
2003-03-04 |
2006-06-30 |
Altana Pharma Ag |
Purin-6-one-derivatives
|
|
EP1613747A1
(en)
|
2003-03-31 |
2006-01-11 |
Pfizer Products Inc. |
Crystal structure of 3 ,5 -cyclic nucleotide phosphodiesterase 1b (pde1b) and uses thereof
|
|
JP2006522151A
(ja)
|
2003-04-01 |
2006-09-28 |
アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ |
不妊症におけるホスホジエステラーゼ阻害剤
|
|
US7268133B2
(en)
*
|
2003-04-23 |
2007-09-11 |
Pfizer, Inc. Patent Department |
Cannabinoid receptor ligands and uses thereof
|
|
WO2005041957A1
(en)
|
2003-10-29 |
2005-05-12 |
Pfizer Products Inc. |
Oxindole derivatives and their use as phosphodiesterase type 2 inhibitors
|
|
CA2549510A1
(en)
|
2003-12-16 |
2005-07-07 |
Pfizer Products Inc. |
Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
|
|
EP1548011A1
(en)
|
2003-12-23 |
2005-06-29 |
Neuro3D |
Benzo[1,4]diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof
|
|
WO2005083069A1
(en)
*
|
2004-01-30 |
2005-09-09 |
Pfizer Products Inc. |
Pde2 crystal structures for structure based drug design
|
|
WO2006024640A2
(en)
|
2004-09-02 |
2006-03-09 |
Altana Pharma Ag |
Triazolophthalazines
|
|
MX2007008137A
(es)
|
2005-01-05 |
2007-07-19 |
Altana Pharma Ag |
Triazoloftalazinas como inhibidores de pde2.
|
|
JP5130053B2
(ja)
|
2005-01-05 |
2013-01-30 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
トリアゾロフタラジン
|
|
DOP2006000009A
(es)
*
|
2005-01-13 |
2006-08-15 |
Arena Pharm Inc |
Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina
|
|
WO2006133261A2
(en)
|
2005-06-06 |
2006-12-14 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
EP1749824A1
(en)
|
2005-08-03 |
2007-02-07 |
Neuro3D |
Benzodiazepine derivatives, their preparation and the therapeutic use thereof
|
|
EP1919287A4
(en)
|
2005-08-23 |
2010-04-28 |
Intra Cellular Therapies Inc |
ORGANIC COMPOUNDS FOR TREATING A REDUCED DOPAMINE RECEPTOR SIGNALING ACTIVITY
|
|
WO2007032466A1
(ja)
|
2005-09-15 |
2007-03-22 |
Aska Pharmaceutical Co., Ltd. |
複素環化合物、その製造方法並びに用途
|
|
WO2007047978A2
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
AU2007256633B2
(en)
|
2006-06-06 |
2013-09-12 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2008063505A1
(en)
|
2006-11-13 |
2008-05-29 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2008070095A1
(en)
|
2006-12-05 |
2008-06-12 |
Intra-Cellular Therapies, Inc. |
Novel uses
|
|
PT2152712E
(pt)
|
2007-05-11 |
2012-02-29 |
Pfizer |
Compostos amino-heterocíclicos
|
|
US7807629B1
(en)
|
2007-06-05 |
2010-10-05 |
Alcon Research, Ltd. |
Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma
|
|
ES2588238T3
(es)
|
2007-12-06 |
2016-10-31 |
Intra-Cellular Therapies, Inc. |
Derivados de pirazolopirimidin-4,6-diona y su uso como producto farmacéutico
|
|
EP2939676A1
(en)
|
2007-12-06 |
2015-11-04 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2010062366A1
(en)
|
2008-10-31 |
2010-06-03 |
Arginetix, Inc. |
Compositions and methods of treating endothelial disorders
|
|
US20100120763A1
(en)
|
2008-11-07 |
2010-05-13 |
Wyeth |
Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases
|
|
WO2010054253A1
(en)
|
2008-11-07 |
2010-05-14 |
Biotie Therapies Gmbh |
Triazine derivatives as inhibitors of phosphodiesterases
|
|
AU2009322903A1
(en)
|
2008-12-06 |
2010-06-10 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
BRPI0922700A2
(pt)
|
2008-12-06 |
2015-08-11 |
Intracellular Therapies Inc |
Compostos orgânicos
|
|
AU2009322899A1
(en)
|
2008-12-06 |
2010-06-10 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
MX2011005934A
(es)
|
2008-12-06 |
2011-12-16 |
Intra Cellular Therapies Inc |
Compuestos organicos.
|
|
EA201170769A1
(ru)
|
2008-12-06 |
2012-02-28 |
Интра-Селлулар Терапиз, Инк. |
Органические соединения
|
|
PE20110922A1
(es)
|
2008-12-06 |
2012-01-22 |
Intra Cellular Therapies Inc |
DERIVADOS DE PIRAZOLO[4,3-e]PIRIMIDIN COMO INHIBIDORES DE LA FOSFODIESTERASA 1 (PDE1)
|
|
WO2010098839A1
(en)
|
2009-02-25 |
2010-09-02 |
Intra-Cellular Therapies, Inc. |
Pde 1 inhibitors for ophthalmic disorders
|
|
EP2434895A4
(en)
|
2009-05-13 |
2013-08-07 |
Intra Cellular Therapies Inc |
ORGANIC CONNECTIONS
|
|
WO2011011312A1
(en)
|
2009-07-22 |
2011-01-27 |
Merck Sharp & Dohme Corp. |
Quinolinone pde2 inhibitors
|
|
US8858911B2
(en)
|
2009-10-08 |
2014-10-14 |
Intra-Cellular Therapies, Inc. |
Phosphodiesterase 1-targeting tracers and methods
|
|
EP2490693A4
(en)
|
2009-10-19 |
2013-02-27 |
Merck Sharp & Dohme |
Pyrazolo [3,4-B] PYRIDINE-4-ON-KINASE INHIBITORS
|
|
TW201206937A
(en)
|
2010-05-31 |
2012-02-16 |
Intra Cellular Therapies Inc |
Organic compounds
|
|
US9371327B2
(en)
|
2010-05-31 |
2016-06-21 |
Intra-Cellular Therapies, Inc. |
PDE1 inhibitor compounds
|
|
US9763948B2
(en)
|
2010-05-31 |
2017-09-19 |
Intra-Cellular Therapies, Inc. |
PDE1 inhibitory compounds and methods
|
|
EP2575817A4
(en)
|
2010-05-31 |
2014-01-08 |
Intra Cellular Therapies Inc |
ORGANIC CONNECTIONS
|
|
US9540379B2
(en)
|
2011-01-31 |
2017-01-10 |
Boehringer Ingelheim International Gmbh |
(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases
|
|
JP5543039B2
(ja)
|
2011-02-23 |
2014-07-09 |
ファイザー・インク |
神経障害治療のためのイミダゾ［５，１−ｆ］［１，２，４］トリアジン
|
|
KR101626681B1
(ko)
*
|
2011-06-07 |
2016-06-01 |
화이자 인코포레이티드 |
피라졸로[3,4-d]피리미딘 화합물 및 pde2 억제제 및/또는 cyp3a4 억제제로서의 이의 용도
|
|
EP2717877B1
(en)
|
2011-06-10 |
2017-11-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
JP6115962B2
(ja)
|
2011-06-27 |
2017-04-19 |
ヤンセン ファーマシューティカ エヌ．ベー． |
１−アリール−４−メチル−［１，２，４］トリアゾロ［４，３−ａ］キノキサリン誘導体
|
|
WO2013034758A1
(en)
|
2011-09-09 |
2013-03-14 |
H. Lundbeck A/S |
Substituted triazolopyrazines and uses thereof
|
|
WO2013034755A1
(en)
|
2011-09-09 |
2013-03-14 |
H. Lundbeck A/S |
Triazolopyrazine derivatives and their use for treating neurological and psychiatric disorders
|
|
US9056863B2
(en)
|
2011-09-09 |
2015-06-16 |
H. Lundbeck A/S |
Substituted 2,3,5,9,9B-pentaazacyclopenta[a]naphthalenes and uses thereof
|
|
AR091507A1
(es)
|
2012-06-21 |
2015-02-11 |
Intra Cellular Therapies Inc |
SALES DE (6aR,9aS)-5,6a,7,8,9,9a-HEXAHIDRO-5-METIL-3-(FENILAMINO)-2-((4-(6-FLUOROPIRIDIN-2-IL)FENIL)METIL)-CICLOPENT[4,5]IMIDAZO[1,2-a]PIRAZOLO[4,3-e]PIRIMIDIN-4(2H)-ONA
|
|
DK2970279T3
(da)
|
2013-03-15 |
2020-11-30 |
Intra Cellular Therapies Inc |
Organiske forbindelser
|
|
ES2633440T3
(es)
|
2013-03-25 |
2017-09-21 |
Sanofi |
Derivados de pirazolonaftiridinona como inhibidores de metAP2 (metionina aminopeptidasa 2).
|
|
US9546175B2
(en)
|
2014-08-07 |
2017-01-17 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|